Calprotectin as a biomarker in rheumatoid arthritis : the potential predictive value of response to treatment
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Bioanalysis - 15(2023), 18 vom: 16. Sept., Seite 1111-1113 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Caproli, Alessia [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 18.09.2023 Date Revised 04.10.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.4155/bio-2023-0130 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360836496 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360836496 | ||
| 003 | DE-627 | ||
| 005 | 20231226083850.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4155/bio-2023-0130 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1202.xml |
| 035 | |a (DE-627)NLM360836496 | ||
| 035 | |a (NLM)37584369 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Caproli, Alessia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Calprotectin as a biomarker in rheumatoid arthritis |b the potential predictive value of response to treatment |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.09.2023 | ||
| 500 | |a Date Revised 04.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a abatacept | |
| 650 | 4 | |a biological drugs | |
| 650 | 4 | |a biomarker | |
| 650 | 4 | |a calprotectin | |
| 650 | 4 | |a chemiluminescence | |
| 650 | 4 | |a chronic arthritis | |
| 650 | 4 | |a immunology | |
| 650 | 4 | |a predictive value | |
| 650 | 4 | |a rheumatoid arthritis | |
| 650 | 4 | |a synovitis | |
| 650 | 7 | |a Leukocyte L1 Antigen Complex |2 NLM | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a Antirheumatic Agents |2 NLM | |
| 700 | 1 | |a Pina, Silvia Della |e verfasserin |4 aut | |
| 700 | 1 | |a Vezzoli, Marika |e verfasserin |4 aut | |
| 700 | 1 | |a Cavazzana, Ilaria |e verfasserin |4 aut | |
| 700 | 1 | |a Airò, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Brugnoni, Duilio |e verfasserin |4 aut | |
| 700 | 1 | |a Franceschini, Franco |e verfasserin |4 aut | |
| 700 | 1 | |a Garrafa, Emirena |e verfasserin |4 aut | |
| 700 | 1 | |a Piantoni, Silvia |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bioanalysis |d 2009 |g 15(2023), 18 vom: 16. Sept., Seite 1111-1113 |w (DE-627)NLM196969840 |x 1757-6199 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:18 |g day:16 |g month:09 |g pages:1111-1113 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4155/bio-2023-0130 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2023 |e 18 |b 16 |c 09 |h 1111-1113 | ||